🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recent studies suggest that patients with metastatic melanoma whose gut mic...
Status
Completed
Location
Ambroise Paré
Start Date
2022-01-20
Trial ID
NCT04988841
Treatments Being Tested
This phase I trial studies the side effects and best dose of ipilimumab and...
Status
Completed
Location
Yale University
Start Date
2012-12-14
Trial ID
NCT01757639
Treatments Being Tested
This randomized phase II trial studies how well nivolumab works with or wit...
Status
Completed
Location
Sutter Auburn Faith Hospital
Start Date
2015-08-10
Trial ID
NCT02498600
Treatments Being Tested
To assess the safety and tolerability, characterize the dose-limiting toxic...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2012-12
Trial ID
NCT01750580
Treatments Being Tested
JTX-2011-201 is a Phase 2, open label clinical study of vopratelimab (JTX-2...
Status
Completed
Location
Beverly Hills Cancer Center
Start Date
2019-06-06
Trial ID
NCT03989362
Treatments Being Tested
This is an open-label randomized phase II study. Patients are randomized so...
Status
Withdrawn
Location
University of California
Start Date
2015-06
Trial ID
NCT01530984
Treatments Being Tested
This phase II trial studies how well high-dose aldesleukin and ipilimumab w...
Status
Terminated
Location
Loyola University Medical Center
Start Date
2014-11-26
Trial ID
NCT02203604
Treatments Being Tested
The study is studying the joint contribution and interactions of germline v...
Status
Active Not Recruiting
Location
Hospital das Clínicas da Faculdade de Medicina de Ribeirao Preto - USP
Start Date
2022-01-18
Trial ID
NCT05215470
Treatments Being Tested
This research study is studying a drug combination of nivolumab and ipilimu...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2019-03-08
Trial ID
NCT03789110
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of nivolumab w...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-12-16
Trial ID
NCT02696993